{"id":30192,"date":"2024-12-05T15:45:11","date_gmt":"2024-12-05T05:45:11","guid":{"rendered":"https:\/\/template.reachmarkets.com.au\/investorportal\/?p=30192"},"modified":"2025-01-15T07:45:13","modified_gmt":"2025-01-14T21:45:13","slug":"mariam-mansour-staff-profile","status":"publish","type":"post","link":"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/","title":{"rendered":"Mariam Mansour Staff Profile"},"content":{"rendered":"\n<section id=\"investor-briefing\" class=\"wp-block-gutentor-m3 section-gmb4c0540 gutentor-module gutentor-container-cover has-image-bg has-custom-bg\"><div class=\"grid-container\">\n<section id=\"gm8eada6c\" class=\"wp-block-gutentor-m4 section-gm8eada6c gutentor-module gutentor-advanced-columns\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gm38e284\" class=\"wp-block-gutentor-m4-col col-gm38e284 gutentor-single-column  grid-lg-12 grid-md-12 grid-12\"><div id=\"section-gm38e284\" class=\"section-gm38e284 gutentor-col-wrap\">\n<h2 class=\"wp-block-heading has-text-align-center has-white-color has-text-color\" style=\"font-size:33px\">Prescient Therapeutics: Mariam Mansour, PhD<\/h2>\n\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><\/p>\n<\/div><\/div>\n<\/div><\/div><\/section>\n\n\n\n<section id=\"gm8b66bc4\" class=\"wp-block-gutentor-m4 section-gm8b66bc4 gutentor-module gutentor-advanced-columns\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gmce8f0b\" class=\"wp-block-gutentor-m4-col col-gmce8f0b gutentor-single-column  grid-lg-7 grid-md-6 grid-12\"><div id=\"section-gmce8f0b\" class=\"section-gmce8f0b gutentor-col-wrap\">\n<figure class=\"wp-block-image size-full showvi\"><img loading=\"lazy\" decoding=\"async\" width=\"650\" height=\"360\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/12\/PTX-QA-Mariam-Mansour.png\" alt=\"\" class=\"wp-image-30226\" srcset=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/12\/PTX-QA-Mariam-Mansour.png 650w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/12\/PTX-QA-Mariam-Mansour-300x166.png 300w\" sizes=\"auto, (max-width: 650px) 100vw, 650px\" \/><\/figure>\n\n\n\n<script src=\"https:\/\/ajax.googleapis.com\/ajax\/libs\/jquery\/3.5.1\/jquery.min.js\"><\/script>\n<script type=\"text\/javascript\"> \njQuery(document).ready(function ($) {\n    $('.showvi').click(function(e) {\n    e.preventDefault();\n  $('.showvi').html('<iframe loading=\"lazy\" src=\"https:\/\/player.vimeo.com\/video\/1045178021?title=0&#038;byline=0&#038;portrait=0\" width=\"100%\" height=\"410\" frameborder=\"0\" allow=\"autoplay; fullscreen\" allowfullscreen><\/iframe>');\n});\n});\n\n <\/script>\n<script type=\"text\/javascript\">jQuery(document).ready(function($){\n    $(\".showvi\").append(\"<img class='play-icon play-video' src='https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2022\/07\/playvideo-3-1.svg' \/>\");\n});<\/script>\n<\/div><\/div>\n\n\n\n<div id=\"col-gm89b923\" class=\"wp-block-gutentor-m4-col col-gm89b923 gutentor-single-column  grid-lg-5 grid-md-6 grid-12 homepage-custom\"><div id=\"section-gm89b923\" class=\"section-gm89b923 gutentor-col-wrap\">\n<p class=\"has-white-color has-text-color\">Mariam Mansour, PhD, Director of Clinical Development and Translational Sciences at Prescient, shares insights into PTX\u2019s therapy portfolio, her experience so far, and her vision for the company\u2019s future.<a href=\"https:\/\/cwhlz04.na1.hubspotlinks.com\/Ctc\/LY+113\/cWHlz04\/VVBv5T1m0d4TW1XRfw_3VQ1mxW4FBnYy5plFKhN7swVx23qn9gW8wLKSR6lZ3mnW96PLm75vg61GW7hpcv91WrpYrW5mmq9p6PyB19Vlyd0s6Rdyy8W3mVGVt5jrN49W3NPjPQ5h4fbxW4DLpyD1c5zBZW2j1Pd-6KBgYrW1yq9GS2Z9JTLVV5FpK1JsB98W3mQ8sN2cfhPqVCpFMj26PrkLN2C1dwRH66WYW4FwDtB6VJX01W3FfvPd3_T7s0W7Cwpbb5PNjDVMYZClTnX1VVW4kWpfc1yBpQnN8h5c4_RYg5_W9jrk686tgGH2W5nPKkX51DJLzW3rDzZb8QPk1MW2qH9p22L8R2gW4BW0Bq7RM7-pW6LB1T87TBQQkW85hPpm1hGh2MVfX9qL3g80n4W5sPPSV5pRxkzdcxz4C04\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/p>\n\n\n\n<p class=\"has-white-color has-text-color\">In this video, Mariam discusses:<\/p>\n\n\n\n<ul class=\"wp-block-list white\">\n<li>Why she believes Prescient is delivering impactful benefits, having moved beyond the \u201cfishing expedition\u201d phase.<\/li>\n\n\n\n<li>Her role in PTX\u2019s CellPryme program and the promising results achieved so far.<\/li>\n\n\n\n<li>Her vision for Prescient, bolstered by the successful PTX-100 Phase 1b trial outcomes, a solid foundation, and growing momentum.<\/li>\n<\/ul>\n\n\n\n<p><\/p>\n\n\n\n<p class=\"has-white-color has-text-color\">Recorded on 5 December 2024 at 2pm (AEDT)<\/p>\n\n\n\n<p><a href=\"https:\/\/template.reachmarkets.com.au\/investorportal\/investor-briefing\/\">Join the next Prescient Therapeutics webcast<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/template.reachmarkets.com.au\/investorportal\/register\/\">Register to stay up to date with Prescient Therapeutics<\/a><\/p>\n<\/div><\/div>\n<\/div><\/div><\/section>\n\n\n\n<section id=\"bio\" class=\"wp-block-gutentor-m3 alignwide section-gm8741d08 gutentor-module gutentor-container-cover custom-fullwidth\"><div class=\"grid-container\">\n<h4 class=\"wp-block-heading speak has-text-color\" style=\"color:#ffcc00\">Featured Speaker<\/h4>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-center speaker-heading has-white-color has-text-color\"><\/h3>\n\n\n\n<section id=\"gmb12de2c\" class=\"wp-block-gutentor-m4 section-gmb12de2c gutentor-module gutentor-advanced-columns\"><div class=\"grid-container\"><div class=\"grid-row\">\n<div id=\"col-gm4e74d2\" class=\"wp-block-gutentor-m4-col col-gm4e74d2 gutentor-single-column  grid-lg-3 grid-md-12 grid-12\"><div id=\"section-gm4e74d2\" class=\"section-gm4e74d2 gutentor-col-wrap\"><\/div><\/div>\n\n\n\n<div id=\"col-gm62f786\" class=\"wp-block-gutentor-m4-col col-gm62f786 gutentor-single-column  grid-lg-6 grid-md-12 grid-12\"><div id=\"section-gm62f786\" class=\"section-gm62f786 gutentor-col-wrap\">\n<figure class=\"wp-block-image size-full speaker-img\"><img loading=\"lazy\" decoding=\"async\" width=\"1019\" height=\"1015\" src=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/12\/Mariam-Mansour-Profile.jpg\" alt=\"\" class=\"wp-image-30228\" srcset=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/12\/Mariam-Mansour-Profile.jpg 1019w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/12\/Mariam-Mansour-Profile-300x300.jpg 300w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/12\/Mariam-Mansour-Profile-150x150.jpg 150w, https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/12\/Mariam-Mansour-Profile-768x765.jpg 768w\" sizes=\"auto, (max-width: 1019px) 100vw, 1019px\" \/><\/figure>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-center speaker-heading has-white-color has-text-color\">Mariam Mansour, PhD<\/h3>\n\n\n\n<h4 class=\"wp-block-heading has-text-align-center speaker-title has-white-color has-text-color\">Director of Clinical Development and Translational Sciences<\/h4>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"has-text-align-center speaker-bio has-white-color has-text-color\">With over 17 years of experience in clinical development, Mariam Monsour, PhD, is an accomplished expert in biologics, gene, and cell therapies. Formerly the Research and Clinical Lead at CSL and a Senior Research Fellow at Peter MacCallum Cancer Centre, she has driven immuno-oncology advancements and led preclinical development initiatives for early-stage portfolio assets at Bristol Myers Squibb and Genentech. Her extensive expertise includes developing therapeutic portfolio strategies, managing clinical pipelines, and implementing biomarker and bioanalytical strategies to support nonclinical, GLP toxicology, pharmacology, and GCP clinical studies.<\/p>\n<\/div><\/div>\n\n\n\n<div id=\"col-gm6380be\" class=\"wp-block-gutentor-m4-col col-gm6380be gutentor-single-column  grid-lg-3 grid-md-12 grid-12\"><div id=\"section-gm6380be\" class=\"section-gm6380be gutentor-col-wrap\">\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"wp-block-heading has-text-align-center speaker-heading has-white-color has-text-color\"><\/h3>\n<\/div><\/div>\n<\/div><\/div><\/section>\n<\/div><\/section>\n<\/div><\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":10,"featured_media":30226,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[29],"class_list":["post-30192","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-prescient-therapeutics"],"gutentor_comment":0,"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mariam Mansour Staff Profile - PTX Therapeutics<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mariam Mansour Staff Profile - PTX Therapeutics\" \/>\n<meta property=\"og:url\" content=\"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/\" \/>\n<meta property=\"og:site_name\" content=\"PTX Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-05T05:45:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-14T21:45:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/12\/PTX-QA-Mariam-Mansour.png\" \/>\n\t<meta property=\"og:image:width\" content=\"650\" \/>\n\t<meta property=\"og:image:height\" content=\"360\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Daniella Watson\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Daniella Watson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/\"},\"author\":{\"name\":\"Daniella Watson\",\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/#\/schema\/person\/4aae9d23fb2bf988bb3cc911a869c24d\"},\"headline\":\"Mariam Mansour Staff Profile\",\"datePublished\":\"2024-12-05T05:45:11+00:00\",\"dateModified\":\"2025-01-14T21:45:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/\"},\"wordCount\":212,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/12\/PTX-QA-Mariam-Mansour.png\",\"keywords\":[\"Prescient Therapeutics\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/\",\"url\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/\",\"name\":\"Mariam Mansour Staff Profile - PTX Therapeutics\",\"isPartOf\":{\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/12\/PTX-QA-Mariam-Mansour.png\",\"datePublished\":\"2024-12-05T05:45:11+00:00\",\"dateModified\":\"2025-01-14T21:45:13+00:00\",\"author\":{\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/#\/schema\/person\/4aae9d23fb2bf988bb3cc911a869c24d\"},\"breadcrumb\":{\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/#primaryimage\",\"url\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/12\/PTX-QA-Mariam-Mansour.png\",\"contentUrl\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/12\/PTX-QA-Mariam-Mansour.png\",\"width\":650,\"height\":360},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mariam Mansour Staff Profile\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/#website\",\"url\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/\",\"name\":\"PTX Therapeutics\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/#\/schema\/person\/4aae9d23fb2bf988bb3cc911a869c24d\",\"name\":\"Daniella Watson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a7f9f6be6da4032f9e1867834f85f771d506fcb997cf479b6b4cb55683c78e64?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a7f9f6be6da4032f9e1867834f85f771d506fcb997cf479b6b4cb55683c78e64?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a7f9f6be6da4032f9e1867834f85f771d506fcb997cf479b6b4cb55683c78e64?s=96&d=mm&r=g\",\"caption\":\"Daniella Watson\"},\"url\":\"https:\/\/template.reachmarkets.com.au\/investorportal\/author\/daniella\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mariam Mansour Staff Profile - PTX Therapeutics","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Mariam Mansour Staff Profile - PTX Therapeutics","og_url":"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/","og_site_name":"PTX Therapeutics","article_published_time":"2024-12-05T05:45:11+00:00","article_modified_time":"2025-01-14T21:45:13+00:00","og_image":[{"width":650,"height":360,"url":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/12\/PTX-QA-Mariam-Mansour.png","type":"image\/png"}],"author":"Daniella Watson","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Daniella Watson","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/#article","isPartOf":{"@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/"},"author":{"name":"Daniella Watson","@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/#\/schema\/person\/4aae9d23fb2bf988bb3cc911a869c24d"},"headline":"Mariam Mansour Staff Profile","datePublished":"2024-12-05T05:45:11+00:00","dateModified":"2025-01-14T21:45:13+00:00","mainEntityOfPage":{"@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/"},"wordCount":212,"commentCount":0,"image":{"@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/#primaryimage"},"thumbnailUrl":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/12\/PTX-QA-Mariam-Mansour.png","keywords":["Prescient Therapeutics"],"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/","url":"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/","name":"Mariam Mansour Staff Profile - PTX Therapeutics","isPartOf":{"@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/#website"},"primaryImageOfPage":{"@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/#primaryimage"},"image":{"@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/#primaryimage"},"thumbnailUrl":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/12\/PTX-QA-Mariam-Mansour.png","datePublished":"2024-12-05T05:45:11+00:00","dateModified":"2025-01-14T21:45:13+00:00","author":{"@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/#\/schema\/person\/4aae9d23fb2bf988bb3cc911a869c24d"},"breadcrumb":{"@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/#primaryimage","url":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/12\/PTX-QA-Mariam-Mansour.png","contentUrl":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-content\/uploads\/2024\/12\/PTX-QA-Mariam-Mansour.png","width":650,"height":360},{"@type":"BreadcrumbList","@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/mariam-mansour-staff-profile\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/template.reachmarkets.com.au\/investorportal\/"},{"@type":"ListItem","position":2,"name":"Mariam Mansour Staff Profile"}]},{"@type":"WebSite","@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/#website","url":"https:\/\/template.reachmarkets.com.au\/investorportal\/","name":"PTX Therapeutics","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/template.reachmarkets.com.au\/investorportal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/template.reachmarkets.com.au\/investorportal\/#\/schema\/person\/4aae9d23fb2bf988bb3cc911a869c24d","name":"Daniella Watson","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a7f9f6be6da4032f9e1867834f85f771d506fcb997cf479b6b4cb55683c78e64?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a7f9f6be6da4032f9e1867834f85f771d506fcb997cf479b6b4cb55683c78e64?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a7f9f6be6da4032f9e1867834f85f771d506fcb997cf479b6b4cb55683c78e64?s=96&d=mm&r=g","caption":"Daniella Watson"},"url":"https:\/\/template.reachmarkets.com.au\/investorportal\/author\/daniella\/"}]}},"_links":{"self":[{"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/posts\/30192","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/comments?post=30192"}],"version-history":[{"count":5,"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/posts\/30192\/revisions"}],"predecessor-version":[{"id":30229,"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/posts\/30192\/revisions\/30229"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/media\/30226"}],"wp:attachment":[{"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/media?parent=30192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/categories?post=30192"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/template.reachmarkets.com.au\/investorportal\/wp-json\/wp\/v2\/tags?post=30192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}